NCT00010283 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Status COMPLETED Phase PHASE1/PHASE2
NCT00006968 Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00006864 Interleukin-2 in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE4
NCT00006483 Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung Status COMPLETED Phase PHASE2
NCT00006384 SU5416 and Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00006255 Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases Status COMPLETED Phase PHASE2
NCT00006126 Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Small Cell Lung, Breast, Testicular, or Kidney Cancer That is Metastatic or That Cannot Be Treated With Surgery Status WITHDRAWN Phase PHASE1
NCT00006022 Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer Status COMPLETED Phase PHASE1
NCT00005966 Interferon Alfa-2b With or Without Thalidomide in Treating Patients With Metastatic or Unresectable Kidney Cancer Status COMPLETED Phase PHASE3
NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00005816 Vaccine Therapy in Treating Patients With Stage III or Stage IV Kidney Cancer Status COMPLETED Phase PHASE1
NCT00005069 Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer Status COMPLETED Phase PHASE2
NCT00005056 Bryostatin 1 In Treating Patients With Progressive Kidney Cancer Status COMPLETED Phase PHASE2
NCT00005045 Carboxyamidotriazole in Treating Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE2
NCT00005038 Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer Status UNKNOWN Phase PHASE2
NCT00005027 Rebeccamycin Analog in Treating Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE2
NCT00004890 Biomed 101 and Interleukin-2 in Treating Patients With Kidney Cancer Status COMPLETED Phase PHASE1
NCT00004880 Vaccine Therapy in Treating Patients With Advanced Kidney Cancer Status COMPLETED Phase PHASE1
NCT00004879 Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer Status COMPLETED Phase PHASE1